# Bioxytran Finishes Production of Two New Dietary Supplements

- URL: https://stocks.freetheai.org/news/bioxytran-finishes-production-of-two-new-dietary-supplements-4c5e7b
- Published: 2026-10-19T11:00:00Z
- Category: company_news; sentiment: neutral; impact: low
- Symbols: [OTC:BIXT](https://stocks.freetheai.org/symbols/OTC-BIXT)
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

Bioxytran, Inc. (OTC: BIXT) finished manufacturing inventory for two new dietary supplements, V-LO and A-SUQAR, marking a step toward commercial sales. V-LO is a plant-based chewable tablet designed to support normal immune function, while A-SUQAR is designed to support healthy post-meal blood sugar levels that are already in a normal range.

The move into consumer products establishes a commercial revenue opportunity separate from the clinical-stage biotechnology company's main pharmaceutical research activities. Bioxytran previously established a distribution partnership with Khoury Medical LTD in February 2026 to bring A-SUQAR to markets in the Middle East.

The company is currently finalizing its sales, marketing, and distribution plans across retail, e-commerce, and regional partners. Exact launch timing and product availability will be announced after go-to-market arrangements are finalized.

## Key points

- Bioxytran, Inc. (OTC: BIXT) completed production of finished inventory for dietary supplements V-LO and A-SUQAR.
- V-LO supports normal immune health, while A-SUQAR supports healthy post-meal blood sugar levels within normal range.
- The commercial supplement business operates separately from Bioxytran's clinical-stage pharmaceutical pipeline.
- Bioxytran holds a distribution deal with Khoury Medical LTD for Middle East distribution of A-SUQAR.
- Go-to-market plans covering e-commerce and retail channels are being finalized prior to setting launch dates.

## Questions and answers

### What products did Bioxytran finish manufacturing?

Bioxytran completed production of finished inventory for V-LO, an immune health supplement, and A-SUQAR, a supplement designed to support healthy post-meal blood sugar levels.

### How will Bioxytran sell V-LO and A-SUQAR?

Bioxytran is finalizing go-to-market plans across e-commerce, retail, and distribution partners. It also holds a commercial distribution agreement with Khoury Medical LTD for A-SUQAR in the Middle East.

### Is Bioxytran dropping its pharmaceutical programs?

No. Bioxytran operates its consumer dietary supplement business separately from its core pharmaceutical development programs.